Literature DB >> 20083307

Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.

Mark R Karver1, Divya Krishnamurthy, Nunzio Bottini, Amy M Barrios.   

Abstract

Selective protein tyrosine phosphatase (PTP) inhibition is often difficult to achieve owing to the high degree of similarity of the catalytic domains of this family of enzymes. Selective inhibitors of the lymphoid specific tyrosine phosphatase, LYP, are of great interest due to the involvement of LYP in several autoimmune disorders. This manuscript describes a study into the mechanistic details of selective LYP inhibition by a Au(I)-phosphine complex. The complex, [Au((CH(2)CH(2)CN)(2)PPh)Cl], selectively inhibits LYP activity both in vitro and in cells, but does not inhibit other T-cell derived PTPs including the highly homologous PTP-PEST. The mode of inhibition was probed by investigating inhibition of LYP, the LYP mutant C129/231S, and PTP-PEST. Inhibition of LYP and PTP-PEST was competitive, while the LYP double mutant appeared mixed. Wild-type LYP was inhibited more potently than LYP C129/231S, indicating an important role for at least one of these residues in Au(I) binding. Coordination of Au(I) by both the active site cysteine residue as well as either Cys129 or 231 is suggested as a potential mechanism for LYP selective inhibition. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20083307      PMCID: PMC2873867          DOI: 10.1016/j.jinorgbio.2009.12.012

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  24 in total

Review 1.  Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

Authors:  Zhong-Yin Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes.

Authors:  B M Sutton; E McGusty; D T Walz; M J DiMartino
Journal:  J Med Chem       Date:  1972-11       Impact factor: 7.446

3.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.

Authors:  A Weiss; J D Stobo
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

4.  Essential function of PTP-PEST during mouse embryonic vascularization, mesenchyme formation, neurogenesis and early liver development.

Authors:  Jacinthe Sirois; Jean-François Côté; Alain Charest; Noriko Uetani; Annie Bourdeau; Stephen A Duncan; Eugene Daniels; Michel L Tremblay
Journal:  Mech Dev       Date:  2006-09-01       Impact factor: 1.882

5.  A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.

Authors:  Valeria Orrú; Sophia J Tsai; Blanca Rueda; Edoardo Fiorillo; Stephanie M Stanford; Jhimli Dasgupta; Jaana Hartiala; Lei Zhao; Norberto Ortego-Centeno; Sandra D'Alfonso; Frank C Arnett; Hui Wu; Miguel A Gonzalez-Gay; Betty P Tsao; Bernardo Pons-Estel; Marta E Alarcon-Riquelme; Yantao He; Zhong-Yin Zhang; Hooman Allayee; Xiaojiang S Chen; Javier Martin; Nunzio Bottini
Journal:  Hum Mol Genet       Date:  2008-11-03       Impact factor: 6.150

6.  Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.

Authors:  Chieko Kyogoku; Carl D Langefeld; Ward A Ortmann; Annette Lee; Scott Selby; Victoria E H Carlton; Monica Chang; Paula Ramos; Emily C Baechler; Franak M Batliwalla; Jill Novitzke; Adrienne H Williams; Clarence Gillett; Peter Rodine; Robert R Graham; Kristin G Ardlie; Patrick M Gaffney; Kathy L Moser; Michelle Petri; Ann B Begovich; Peter K Gregersen; Timothy W Behrens
Journal:  Am J Hum Genet       Date:  2004-07-23       Impact factor: 11.025

7.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

8.  Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation .

Authors:  Sophia J Tsai; Udayaditya Sen; Lei Zhao; William B Greenleaf; Jhimli Dasgupta; Edoardo Fiorillo; Valeria Orrú; Nunzio Bottini; Xiaojiang S Chen
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

Review 9.  Chrysotherapy: a synoptic review.

Authors:  R Eisler
Journal:  Inflamm Res       Date:  2003-11-13       Impact factor: 4.575

Review 10.  Protein tyrosine phosphatases in autoimmunity.

Authors:  Torkel Vang; Ana V Miletic; Yutaka Arimura; Lutz Tautz; Robert C Rickert; Tomas Mustelin
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

View more
  7 in total

1.  Substrate selection influences molecular recognition in a screen for lymphoid tyrosine phosphatase inhibitors.

Authors:  Rhushikesh A Kulkarni; Nadeem A Vellore; Matthew R Bliss; Stephanie M Stanford; Matthew D Falk; Nunzio Bottini; Riccardo Baron; Amy M Barrios
Journal:  Chembiochem       Date:  2013-08-16       Impact factor: 3.164

2.  Covalent inhibition of the lymphoid tyrosine phosphatase.

Authors:  Vanessa F Ahmed; Nunzio Bottini; Amy M Barrios
Journal:  ChemMedChem       Date:  2014-01-08       Impact factor: 3.466

Review 3.  Covalent inhibition of protein tyrosine phosphatases.

Authors:  Kasi Viswanatharaju Ruddraraju; Zhong-Yin Zhang
Journal:  Mol Biosyst       Date:  2017-06-27

4.  A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.

Authors:  Yantao He; Sijiu Liu; Ambili Menon; Stephanie Stanford; Emmanuel Oppong; Andrea M Gunawan; Li Wu; Dennis J Wu; Amy M Barrios; Nunzio Bottini; Andrew C B Cato; Zhong-Yin Zhang
Journal:  J Med Chem       Date:  2013-06-06       Impact factor: 7.446

5.  Inhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity.

Authors:  Megan K Thorson; David T Puerta; Seth M Cohen; Amy M Barrios
Journal:  Bioorg Med Chem Lett       Date:  2014-06-16       Impact factor: 2.823

6.  Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.

Authors:  Rhushikesh A Kulkarni; Stephanie M Stanford; Nadeem A Vellore; Divya Krishnamurthy; Matthew R Bliss; Riccardo Baron; Nunzio Bottini; Amy M Barrios
Journal:  ChemMedChem       Date:  2013-07-19       Impact factor: 3.466

Review 7.  Interrogating Protein Phosphatases with Chemical Activity Probes.

Authors:  Garrett R Casey; Cliff I Stains
Journal:  Chemistry       Date:  2018-03-08       Impact factor: 5.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.